308 related articles for article (PubMed ID: 8952536)
1. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
Flenghi L; Fagioli M; Tomassoni L; Pileri S; Gambacorta M; Pacini R; Grignani F; Casini T; Ferrucci PF; Martelli MF
Blood; 1995 Apr; 85(7):1871-80. PubMed ID: 7535592
[TBL] [Abstract][Full Text] [Related]
3. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
4. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
[TBL] [Abstract][Full Text] [Related]
5. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
Yoon GS; Yu E
J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
[TBL] [Abstract][Full Text] [Related]
8. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
9. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
12. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Heuser M; van der Kuip H; Falini B; Peschel C; Huber C; Fischer T
Mediators Inflamm; 1998; 7(5):319-25. PubMed ID: 9883966
[TBL] [Abstract][Full Text] [Related]
13. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
14. Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Gurrieri C; Capodieci P; Bernardi R; Scaglioni PP; Nafa K; Rush LJ; Verbel DA; Cordon-Cardo C; Pandolfi PP
J Natl Cancer Inst; 2004 Feb; 96(4):269-79. PubMed ID: 14970276
[TBL] [Abstract][Full Text] [Related]
15. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi PP; Pelicci PG; Dejean A
Oncogene; 1995 Sep; 11(5):871-6. PubMed ID: 7545807
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
17. Expression of promyelocytic leukaemia protein in thyroid neoplasms.
Yu E; Lee KW; Lee HJ
Histopathology; 2000 Oct; 37(4):302-8. PubMed ID: 11012736
[TBL] [Abstract][Full Text] [Related]
18. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
[TBL] [Abstract][Full Text] [Related]
19. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
20. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
